Back to Search
Start Over
A phase 1/2, open‐label, dose‐escalation study of midostaurin in children with relapsed or refractory acute leukaemia.
- Source :
-
British Journal of Haematology . May2019, Vol. 185 Issue 3, p623-627. 5p. 1 Chart, 1 Graph. - Publication Year :
- 2019
-
Abstract
- The article focuses on the impact of the multikinase inhibitor Midostaurin in children experiencing relapsed acute leukaemia despite past tretaments. It talks about the relapse of acute leukaemia being common in children along with diseases like myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL).
- Subjects :
- *ACUTE myeloid leukemia
*STEM cell transplantation
Subjects
Details
- Language :
- English
- ISSN :
- 00071048
- Volume :
- 185
- Issue :
- 3
- Database :
- Academic Search Index
- Journal :
- British Journal of Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 135934115
- Full Text :
- https://doi.org/10.1111/bjh.15593